S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
These 5 Tech Stocks Have 10x Potential (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony

Medtronic - MDT Price Target & Analyst Ratings

$79.25
+0.21 (+0.27%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$78.92
$80.16
50-Day Range
$76.13
$87.74
52-Week Range
$75.83
$114.44
Volume
7.87 million shs
Average Volume
6.25 million shs
Market Capitalization
$105.34 billion
P/E Ratio
24.61
Dividend Yield
3.44%
Price Target
$97.58

Medtronic Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 23 Analyst Ratings

Consensus Analyst Price Target

$97.58
23.13% Upside
High Prediction$135.00
Average Prediction$97.58
Low Prediction$77.00
TypeCurrent
12/2/21 to 12/2/22
1 Month Ago
11/2/21 to 11/2/22
3 Months Ago
9/3/21 to 9/3/22
1 Year Ago
12/2/20 to 12/2/21
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
15 Buy rating(s)
Hold
16 Hold rating(s)
13 Hold rating(s)
11 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$97.58$108.25$112.10$144.33
Predicted Upside23.13% Upside13.58% Upside13.00% Upside17.40% Upside
Get Medtronic Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.


MDT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medtronic Stock vs. The Competition

TypeMedtronicMedical CompaniesS&P 500
Consensus Rating Score
2.22
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside23.13% Upside575.78% Upside11.38% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
1563
77.30%
Underperform Votes
459
22.70%
Avg. Outperform Votes
163
66.26%
Avg. Underperform Votes
83
33.74%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/30/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$82.00 ➝ $77.00+0.68%
11/25/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$90.00 ➝ $85.00+7.57%
11/23/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$117.00 ➝ $90.00+13.92%
11/23/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$110.00 ➝ $102.00+32.12%
11/23/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$97.00 ➝ $88.00+13.99%
11/23/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$85.00 ➝ $80.00+3.63%
11/23/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$89.00 ➝ $84.00+7.79%
11/23/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$105.00 ➝ $90.00+15.49%
11/23/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$106.00 ➝ $85.00+9.07%
11/23/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$108.00 ➝ $85.00+9.07%
11/22/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$90.00 ➝ $80.00+3.76%
10/12/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+24.49%
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$87.00+6.24%
8/24/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
7/5/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$85.00-6.07%
6/1/2022Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$125.00 ➝ $105.00+4.84%
5/27/2022Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
5/20/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lee Hambright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$122.00+18.99%
4/13/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Antalffy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
3/1/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Buy
2/23/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$142.00 ➝ $135.00+30.16%
1/18/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$129.00 ➝ $115.00+7.35%
1/10/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$104.00-1.10%
12/17/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$130.00 ➝ $105.00+2.73%
8/27/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Toung
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetPositive ➝ Buy$150.00 ➝ $165.00+23.72%
8/25/2021UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$145.00 ➝ $149.00+12.39%
5/27/2021William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kaczor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
11/25/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$120.00 ➝ $128.00+12.22%
5/27/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kaila Krum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$130.00 ➝ $105.00+8.08%
5/23/2020CSFB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$117.00+23.52%
5/21/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeBuy ➝ Strong-Buy$127.00 ➝ $121.00+26.55%
5/14/2020DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$92.00-1.37%
1/2/2020Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$135.00+19.00%
(Data available from 12/2/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












MDT Price Target - Frequently Asked Questions

What is Medtronic's consensus rating and price target?

According to the issued ratings of 23 analysts in the last year, the consensus rating for Medtronic stock is Hold based on the current 1 sell rating, 16 hold ratings and 6 buy ratings for MDT. The average twelve-month price prediction for Medtronic is $97.58 with a high price target of $135.00 and a low price target of $77.00. Learn more on MDT's analyst rating history.

Do Wall Street analysts like Medtronic more than its competitors?

Analysts like Medtronic less than other Medical companies. The consensus rating for Medtronic is Hold while the average consensus rating for medical companies is Buy. Learn more on how MDT compares to other companies.

Do MarketBeat users like Medtronic more than its competitors?

MarketBeat users like Medtronic more than other Medical companies. 77.30% of MarketBeat users gave Medtronic an outperform vote while medical companies recieve an average of 66.26% outperform votes by MarketBeat users.

Is Medtronic being downgraded by Wall Street analysts?

Over the previous 90 days, Medtronic's stock had 3 downgrades by analysts.

Does Medtronic's stock price have much upside?

According to analysts, Medtronic's stock has a predicted upside of 9.79% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:MDT) was last updated on 12/2/2022 by MarketBeat.com Staff